Skip to content

CareDx CDNA Debt-to-equity

Debt-to-equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.8×+0.1×
Natera, Inc. logo
Natera, Inc.NTRA
0.1×0.0×
NeoGenomics logo
NeoGenomicsNEO
0.1×0.0×
Personalis, Inc. logo
Personalis, Inc.PSNL
0.2×0.0×
GeneDx Holdings logo
GeneDx HoldingsWGS
0.4×+0.2×
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
0.8×+0.6×

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
Enterprise value$1.35B-9.7%
P/S3.4×-1.1×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Current ratio3.4×-0.7×

Where this comes from

Calculated from CareDx’s reported figures.

Based on the most recent quarter.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's debt-to-equity?
CareDx (CDNA) reported debt-to-equity of 0.1× in Q1 2026.
How has CareDx's debt-to-equity changed year-over-year?
CareDx's debt-to-equity decreased by 2.1% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for CareDx's debt-to-equity?
Over 5 years (2020 to 2025), CareDx's debt-to-equity has grown at a 5.8% compound annual growth rate (CAGR), from 0.1× to 0.1×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.